Medilink

This is the first in-depth review of the State of the Life Science Start-up sector in the UK. The report looks at where and what type of companies are being formed; where the investment is going and the varied role universities are playing. Author, Dr Glenn Crocker will present key findings and this will be followed by a panel debate on the challenges and opportunities for emerging life science businesses in the current environment.


Confirmed panel members are: Dr Will West, CEO CellCentric; Dr David Hardman, CEO Birmingham Science Park Aston; Mark Warne, Partnership Director, IP Group; Dean Slagel, Managing Director, Esperante Ventures; Lucy P Marcus, CEO Marcus Venture Consulting and Chair of Mobius Life Science Fund.

Attendees of the event will receive a free copy of the report.

For more information on the event and to book your place, please click here.